Advisor OS’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.11M Buy
7,956
+2,263
+40% +$317K 0.08% 171
2025
Q4
$699K Buy
5,693
+453
+9% +$55.1K 0.06% 222
2025
Q3
$582K Sell
5,240
-369
-7% -$41.9K 0.05% 233
2025
Q2
$622K Sell
5,609
-652
-10% -$69.4K 0.06% 217
2025
Q1
$702K Buy
6,261
+1,124
+22% +$116K 0.08% 174
2024
Q4
$474K Buy
5,137
+566
+12% +$51K 0.05% 233
2024
Q3
$383K Buy
4,571
+672
+17% +$51.3K 0.04% 282
2024
Q2
$267K Sell
3,899
-72
-2% -$4.8K 0.03% 323
2024
Q1
$291K Buy
3,971
+242
+6% +$18.6K 0.03% 315
2023
Q4
$302K Buy
3,729
+174
+5% +$13.5K 0.04% 258
2023
Q3
$266K Sell
3,555
-8,466
-70% -$651K 0.04% 245
2023
Q2
$926K Sell
12,021
-7,353
-38% -$586K 0.15% 141
2023
Q1
$1.61M Sell
19,374
-604
-3% -$50K 0.39% 62
2022
Q4
$1.72M Buy
19,978
+4,264
+27% +$338K 0.46% 48
2022
Q3
$970K Buy
15,714
+1,115
+8% +$70.3K 0.29% 74
2022
Q2
$902K Buy
14,599
+5,311
+57% +$329K 0.26% 88
2022
Q1
$552K Buy
9,288
+2,729
+42% +$174K 0.16% 136
2021
Q4
$477K Buy
+6,559
New +$452K 0.1% 172

Other funds holding GILD

Advisor OS's GILD Position: Q1 2026 in Review

Advisor OS increased its Gilead Sciences (GILD) stake by 40% in Q1 2026, buying an estimated $317K and bringing the position to 7,956 shares worth $1.11M. The position accounts for 0.08% of the portfolio, ranked #171.

Advisor OS first reported a position in GILD in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.72M in Q4 2022. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Advisor OS held 7,956 shares of Gilead Sciences worth $1.11M as of Q1 2026.
  • Advisor OS bought 2,263 Gilead Sciences shares in Q1 2026, an estimated $317K.
  • Gilead Sciences made up 0.08% of Advisor OS's portfolio in Q1 2026, its #171 holding.
  • Advisor OS first reported a position in Gilead Sciences in Q4 2021 and has held it in 18 quarters since.
  • Advisor OS's Gilead Sciences position peaked at $1.72M in Q4 2022.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Advisor OS's 13F filing for Q1 2026, filed 8 May 2026.